AIR T INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AIR T INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Mar 31, 2024 | $286.83M | Jun 26, 2024 |
| FY2023 | Mar 31, 2023 | $74.38M | Jun 28, 2023 |
| FY2023 | Dec 31, 2022 | $61.40M | Jun 28, 2023 |
| FY2023 | Sep 30, 2022 | $60.69M | Jun 28, 2023 |
| FY2023 | Jun 30, 2022 | $50.86M | Jun 28, 2023 |
| FY2023 | Mar 31, 2022 | $51.44M | Jun 28, 2023 |
| FY2023 | Dec 31, 2021 | $45.43M | Jun 28, 2023 |
| FY2023 | Sep 30, 2021 | $43.24M | Jun 28, 2023 |
| FY2023 | Jun 30, 2021 | $36.97M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $46.73M | Jun 28, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $291.85M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $286.83M | Aug 12, 2025 |
| FY2022 | Mar 31, 2022 | $177.08M | Jun 28, 2022 |
| FY2022 | Mar 31, 2021 | $175.12M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $236.79M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $215.50M | Jun 26, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($6.14M) | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | ($6.82M) | Aug 12, 2025 |
| FY2023 | Mar 31, 2023 | ($9.04M) | Jun 28, 2023 |
| FY2023 | Dec 31, 2022 | ($590.0K) | Jun 28, 2023 |
| FY2023 | Sep 30, 2022 | ($1.23M) | Jun 28, 2023 |
| FY2023 | Jun 30, 2022 | ($1.43M) | Jun 28, 2023 |
| FY2023 | Mar 31, 2022 | $4.35M | Jun 28, 2023 |
| FY2023 | Dec 31, 2021 | ($1.26M) | Jun 28, 2023 |
| FY2023 | Sep 30, 2021 | $7.56M | Jun 28, 2023 |
| FY2023 | Jun 30, 2021 | $289.0K | Jun 28, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.91M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $1.26M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | ($4.41M) | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $8.76M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | ($9.18M) | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $7.29M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $5.62M | Jun 28, 2019 |
| FY2019 | Dec 31, 2018 | $1.47M | Jun 28, 2019 |
| FY2019 | Sep 30, 2018 | ($1.62M) | Jun 28, 2019 |
| FY2019 | Jun 30, 2018 | $2.60M | Jun 28, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Mar 31, 2018 | $195.7K | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $1.04M | Jun 29, 2018 |
| FY2016 | Mar 31, 2016 | $778.0K | Oct 13, 2017 |
| FY2016 | Mar 31, 2015 | $0 | Oct 13, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $23.50M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $17.18M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $16.91M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | ($33.08M) | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | ($1.82M) | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | ($25.07M) | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $20.94M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | ($277.8K) | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | ($7.55M) | Jun 29, 2018 |
| FY2016 | Mar 31, 2016 | $3.21M | Jun 29, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.08M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $1.08M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $1.18M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $1.53M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $3.90M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $2.44M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $1.17M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | $2.12M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $2.35M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | $1.25M | Oct 13, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $173.78M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $177.17M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $189.56M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $207.60M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $140.75M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $151.43M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $115.14M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | $97.15M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $65.34M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | $52.15M | Oct 13, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $168.24M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $158.37M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $163.87M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $171.12M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $119.44M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $120.34M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $86.31M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | $70.91M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $41.73M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | $16.88M | Oct 13, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($3.22M) | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $4.77M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $11.90M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $24.61M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $13.73M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $24.01M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $24.36M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | $25.12M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $22.97M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | $34.23M | Oct 13, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $10.54M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $10.54M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $10.56M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $10.13M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $4.23M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $4.23M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $4.23M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | $4.42M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $4.42M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | $275.4K | Oct 13, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.13M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $8.19M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $13.69M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $26.73M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $16.27M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $23.77M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $21.19M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | $20.70M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $18.46M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | $28.82M | Oct 13, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.93M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $7.10M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $5.81M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $5.62M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $11.00M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $5.95M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $12.42M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | $4.80M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $2.76M | Jun 29, 2018 |
| FY2018 | Mar 31, 2016 | $5.35M | Jun 29, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $110.33M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | $112.93M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $125.09M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | $135.81M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | $87.50M | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | $85.82M | Jun 25, 2021 |
| FY2019 | Mar 31, 2019 | $57.65M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | $48.08M | Jun 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | (2) | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | (2) | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | (4) | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | 1 | Jun 28, 2023 |
| FY2023 | Dec 31, 2021 | 0 | Jun 28, 2023 |
| FY2023 | Sep 30, 2021 | 2 | Jun 28, 2023 |
| FY2023 | Jun 30, 2021 | 0 | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | (1) | Jun 28, 2022 |
| FY2022 | Dec 31, 2020 | 0 | Jun 28, 2022 |
| FY2022 | Sep 30, 2020 | (1) | Jun 28, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | (2) | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | (2) | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | (4) | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | 3 | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | (1) | Jun 28, 2022 |
| FY2022 | Dec 31, 2020 | 0 | Jun 28, 2022 |
| FY2022 | Sep 30, 2020 | (1) | Jun 28, 2022 |
| FY2022 | Jun 30, 2020 | 0 | Jun 28, 2022 |
| FY2020 | Mar 31, 2020 | 0 | Jun 25, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Jun 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 2.70M | Aug 12, 2025 |
| FY2025 | Mar 31, 2024 | 2.78M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | 2.82M | Jun 26, 2024 |
| FY2023 | Mar 31, 2022 | 2.87M | Jun 28, 2023 |
| FY2022 | Mar 31, 2021 | 2.88M | Jun 28, 2022 |
| FY2019 | Mar 31, 2020 | 2.88M | Jun 26, 2020 |
| FY2019 | Mar 31, 2019 | 2.02M | Jun 26, 2020 |
| FY2019 | Mar 31, 2018 | 2.04M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | 2.04M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | 2.37M | Oct 13, 2017 |